Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors

by Jamila A. Benmoussa, MD, Matthew Clarke, MD, Amulya Penmetsa, MS4, Le Yu Khine, MD, Lina Leykina, MD, Keith Diaz, MD, Philip Otterbeck, MD
Published 2016-12-01